MedTrace Logo

Metabolic Syndrome and Contrast Induced Nephropathy

NCT02192372 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 599

Last updated 2014-07-16

No results posted yet for this study

Summary

Prevention of contrast induced nephropathy after interventional cardiologic procedures deserves close interest because of its association with prolonged hospitalization, increased cost and increased in hospital and long term mortality rates. An observational prospective cohort study was designed to determine whether metabolic syndrome predicts the development of contrast induced nephropathy after elective percutaneous coronary intervention.

Conditions

  • Contrast Induced Nephropathy
  • Metabolic Syndrome

Sponsors & Collaborators

  • Ankara University

    lead OTHER

Principal Investigators

  • Ozgur Ulas Ozcan · Ankara University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02192372 on ClinicalTrials.gov